These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 39140804
1. Tuberostemonine may alleviates proliferation of lung fibroblasts caused by pulmonary fibrosis. Tang A, Liu Y, Ding Q, Huang G, Sha Z, Yang C, Cao F. Int J Immunopathol Pharmacol; 2024; 38():3946320241274225. PubMed ID: 39140804 [Abstract] [Full Text] [Related]
3. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis. Mou F, Mou C. Med Sci Monit; 2020 Feb 05; 26():e919739. PubMed ID: 32019905 [Abstract] [Full Text] [Related]
4. The inhibitory effect of ginsan on TGF-β mediated fibrotic process. Ahn JY, Kim MH, Lim MJ, Park S, Lee SL, Yun YS, Song JY. J Cell Physiol; 2011 May 05; 226(5):1241-7. PubMed ID: 20945375 [Abstract] [Full Text] [Related]
5. Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway. Molagoda IMN, Sanjaya SS, Lee KT, Choi YH, Lee JH, Lee MH, Kang CH, Lee CM, Kim GY. Int J Mol Sci; 2023 Apr 14; 24(8):. PubMed ID: 37108428 [Abstract] [Full Text] [Related]
6. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment]. Jia L, Yang M, Tian X, Zhao P, Mei X, Bai Y. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov 14; 34(11):1161-1166. PubMed ID: 36567559 [Abstract] [Full Text] [Related]
7. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway. Lucarini L, Durante M, Lanzi C, Pini A, Boccalini G, Calosi L, Moroni F, Masini E, Mannaioni G. J Cell Mol Med; 2017 Feb 14; 21(2):324-335. PubMed ID: 27704718 [Abstract] [Full Text] [Related]
8. RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway. Li S, Xu A, Li Y, Tan C, La Regina G, Silvestri R, Wang H, Qi W. Eur J Pharmacol; 2021 Jul 15; 903():174135. PubMed ID: 33940030 [Abstract] [Full Text] [Related]
9. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo. Tao L, Cao J, Wei W, Xie H, Zhang M, Zhang C. Int Immunopharmacol; 2017 Jun 15; 47():38-46. PubMed ID: 28364627 [Abstract] [Full Text] [Related]
10. Inhibition of α-SMA by the ectodomain of FGFR2c attenuates lung fibrosis. Ju W, Zhihong Y, Zhiyou Z, Qin H, Dingding W, Li S, Baowei Z, Xing W, Ying H, An H. Mol Med; 2012 Sep 07; 18(1):992-1002. PubMed ID: 22451267 [Abstract] [Full Text] [Related]
11. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation. Nie Y, Zhang D, Jin Z, Li B, Wang X, Che H, You Y, Qian X, Zhang Y, Zhao P, Chai G. Clin Exp Pharmacol Physiol; 2019 Jun 07; 46(6):575-586. PubMed ID: 30854687 [Abstract] [Full Text] [Related]
12. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis. Usuki J, Matsuda K, Azuma A, Kudoh S, Gemma A. J Nippon Med Sch; 2012 Jun 07; 79(1):46-59. PubMed ID: 22398790 [Abstract] [Full Text] [Related]
13. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo. Qu Y, Zhang G, Ji Y, Zhua H, Lv C, Jiang W. Phytomedicine; 2016 Apr 15; 23(4):350-8. PubMed ID: 27002405 [Abstract] [Full Text] [Related]
14. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro. Pan R, Zhang Y, Zang B, Tan L, Jin M. J Pharm Pharmacol; 2016 Oct 15; 68(10):1320-30. PubMed ID: 27457091 [Abstract] [Full Text] [Related]
15. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway. Li A, Xiao X, Feng ZL, Chen X, Liu LJ, Lin LG, Lu JJ, Zhang LL. Toxicol Appl Pharmacol; 2020 Jan 15; 389():114882. PubMed ID: 31953203 [Abstract] [Full Text] [Related]
16. Ziziphus spina-christi L. extract attenuates bleomycin-induced lung fibrosis in mice via regulating TGF-β1/SMAD pathway: LC-MS/MS Metabolic profiling, chemical composition, and histology studies. Elhady SS, Goda MS, Mehanna ET, El-Sayed NM, Hazem RM, Elfaky MA, Almalki AJ, Mohamed MS, Abdelhameed RFA. Biomed Pharmacother; 2024 Jul 15; 176():116823. PubMed ID: 38834008 [Abstract] [Full Text] [Related]
17. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways. Li J, Feng M, Sun R, Li Z, Hu L, Peng G, Xu X, Wang W, Cui F, Yue W, He J, Liu J. Toxicol Lett; 2020 Mar 15; 321():103-113. PubMed ID: 31706003 [Abstract] [Full Text] [Related]
18. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung. Lucattelli M, Fineschi S, Selvi E, Garcia Gonzalez E, Bartalesi B, De Cunto G, Lorenzini S, Galeazzi M, Lungarella G. Respir Res; 2016 May 06; 17(1):49. PubMed ID: 27153807 [Abstract] [Full Text] [Related]
19. Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling. Zhang Q, Zhang B, Yang F, Hu Y, Fan R, Wang M, Chen S. Phytomedicine; 2024 Jul 25; 130():155715. PubMed ID: 38788399 [Abstract] [Full Text] [Related]
20. A phycocyanin derived eicosapeptide attenuates lung fibrosis development. Li Q, Peng W, Zhang Z, Pei X, Sun Z, Ou Y. Eur J Pharmacol; 2021 Oct 05; 908():174356. PubMed ID: 34280398 [Abstract] [Full Text] [Related] Page: [Next] [New Search]